Vascular and other complications of chemotherapy for testicular cancer

Summary The chronic toxicities of the drug combinations, VBP and VAB-6, which are used to cure patients with metastatic testicular cancer are not well defined. Recently, Raynaud's phenomenon has been reported to occur in 5–35% of patients treated with VBP. Other vascular complications such as renovascular hypertension, myocardial infarctions and cerebrovascular accidents have been anecdotally reported. Since patients with this disease are young, efforts to identify and eliminate chronic drug toxicities are warranted.Supported in part by American Cancer Society Junior Faculty Clinical Fellowship No. 639-A